Company & Sponsor Intelligence
University of Pittsburgh
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials2
Recruiting0
Completed2
Countries1
Therapeutic footprint
alzheimersunclassified
Indexed studies
NCT03305731Activating Behavior for Lasting Engagement After Stroke
stroke · United StatesNA
stroke · United StatesNA
NCT01322022Treatment of Sleep Disturbances in Young Children With Autism
autism · United StatesNA
autism · United StatesNA
NCT03360123Comparison of Triazolam and Midazolam for Anxiolysis During Dental Treatment in the Pediatric Patient
anxiety · United StatesNA
anxiety · United StatesNA
NCT00774150Transdisciplinary Studies of CBT for Anxiety in Youth: Child Anxiety Treatment Study
anxiety · United StatesNA
anxiety · United StatesNA
NCT03982043Text2Connect, Component 2 of iCHART (Integrated Care to Help At-Risk Teens)
depression · United StatesNA
depression · United StatesNA
NCT02939755Web-based Collaborative Care Intervention Study
depression · United StatesNA
depression · United StatesNA
NCT03442322Optimizing Care for Patients With Dementia
alzheimers · United StatesNA
alzheimers · United StatesNA
NCT00129441Gamma-Amino Butyric Acid (GABA)-A Alpha2/3 Study
unclassified · United StatesPHASE2
unclassified · United StatesPHASE2
Intelligence layer updated: 2026-06-10 02:57:56.223123+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →